Cell Source, Inc. | Business Contracts

Third Amended and Restated 10.0% Convertible Note (Filed With SEC on August 12, 2021)

CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on August 14, 2019)

AMENDMENT NO. 1 TO VETO CELL PRODUCTION AND CLINICAL TRIAL PROGRAM AGREEMENT (Filed With SEC on May 20, 2019)

Form of warrant issued to holder of Second Amended and Restated 10.0% Convertible Note (Filed With SEC on April 15, 2021)

Second Amended and Restated 10.0% Convertible Note (Filed With SEC on April 15, 2021)

Form of Warrant issued to Members of Scientific Advisory Board (Filed With SEC on November 13, 2020)

Form of Warrant issued to Purchasers of 8% Convertible Promissory Note (Filed With SEC on November 13, 2020)

Form of 8% Convertible Promissory Note (Filed With SEC on November 13, 2020)

Form of Consultant Stock Option Agreement (Filed With SEC on November 13, 2020)

Form of Director Stock Option Agreement (Filed With SEC on November 13, 2020)

Form of Warrant issued to Service Providers (Filed With SEC on November 13, 2020)

Form of Warrant issued to purchaser of 10% OID Convertible Promissory Note (Filed With SEC on August 14, 2020)

Form of 10% OID Convertible Promissory Note (Filed With SEC on August 14, 2020)

Form of Placement Agent Warrant dated February 13, 2020 (Filed With SEC on May 15, 2020)

Convertible Promissory Note dated January 10, 2020 (Filed With SEC on May 15, 2020)

Convertible Note effective October 28, 2019 (Filed With SEC on March 30, 2020)

CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on August 14, 2019)

CELL SOURCE, INC. 2019 EQUITY INCENTIVE PLAN (Filed With SEC on August 14, 2019)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on April 1, 2019)

§ 1 Subject matter (Filed With SEC on April 1, 2019)

Cell Source, Inc. (24)